2nd Quarter - Report

PODESTA GROUP, INC. for GENZYME

Firm
Client
Income
$130,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Neglected Disease Tax Credit

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus
SHARON COHEN —
DAVID MARIN Press Secretary, Rep. Tom Davis
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
MICHELLE TESSIER —
NICOLE C YOUNG —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Health Issues HCR

Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN New —
TEAL BAKER New Executive Assistant Rep. Brian Baird
PAUL BRATHWAITE New Executive Director, Congressional Black Caucus
SHARON COHEN New —
RANDALL GERARD New —
ARANTHAN JONES New Health Policy Dir., Congressional Black Caucus
ELIZABETH ANN MORRA New 1995-2001 House Appropriations Committee
ANTHONY PODESTA New —
WALTER PRYOR New Staff, Senator David Pryor
DONNI TURNER New Legislative Assistant, Sen. Richard Durbin
NICOLE C YOUNG New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 2502 (111th), S. 1213 (111th), S. 1110 (111th)

Budget/Appropriations BUD

H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85

LobbyistCovered position, as disclosed
SHARON COHEN —
ANDREW KAUDERS Executive Director, House Democratic Caucus
ELIZABETH ANN MORRA —
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1 (111th), S.Con.Res. 13 (111th), H.Con.Res. 85 (111th)

Pharmacy PHA

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Neglected Disease Issues

LobbyistCovered position, as disclosed
TEAL BAKER New Executive Assistant Rep. Brian Baird
PAUL BRATHWAITE Executive Director, Congressional Black Caucus
SHARON COHEN —
ARANTHAN JONES New Health Policy Director Congressional Black Caucus
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
DONNI TURNER New Legislative Assistant, Sen. Richard Durbin
NICOLE C YOUNG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 1427 (111th), S. 726 (111th), H.R. 1548 (111th)

Copyright/Patent/Trademark CPT

S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009

LobbyistCovered position, as disclosed
SHARON COHEN —
COURTNEY HAGEN —
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 515 (111th), H.R. 1260 (111th), S. 610 (111th)

Medicare/Medicaid MMM

Medicare Issues S. 301 Physician Payments Sunshine Act of 2009 Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
TEAL BAKER New Executive Assistant, Rep. Brian Baird
PAUL BRATHWAITE New Executive Director, Congressional Black Caucus
SHARON COHEN —
RANDALL GERARD —
ARANTHAN JONES New Health Policy Dir., Congressional Black Caucus
ELIZABETH ANN MORRA House Appropriations Committee, 1995-2001
ANTHONY PODESTA —
WALTER PRYOR U.S. Senator David Pryor
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
DONNI TURNER New Legislative Assistant, Sen. Richard Durbin
NICOLE C YOUNG —

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 301 (111th), S. 1110 (111th), H.R. 2502 (111th), S. 1213 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.